EGFR and glioblastoma: Interestingly, the potentiating effect of pterostilbene varied among different glioblastoma cultures, correlating with specific genetic mutations like EGFR (Epidermal Growth Factor Receptor) and PIK3CA missense mutations and 1p32 focal deletions, suggesting potential personalized treatment strategies.